Osteopontin expression in salivary gland carcinomas

被引:3
作者
Bjorndal, Kristine [1 ]
Larsen, Stine R. [2 ]
Godballe, Christian [1 ]
Krogdahl, Annelise [2 ]
机构
[1] Odense Univ Hosp, Dept ENT Head & Neck Surg, DK-5000 Odense C, Denmark
[2] Odense Univ Hosp, Dept Pathol, DK-5000 Odense C, Denmark
关键词
immunohistochemistry; osteopontin; prognostic factors; salivary gland carcinomas; CELL LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; PROTEIN EXPRESSION; BREAST-CANCER; ASSOCIATION; PROGRESSION; MARKER; HEAD;
D O I
10.1111/j.1600-0714.2010.00964.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: In several cancer types, osteopontin (OPN) expression has been correlated with tumor progression and prognosis. Two earlier studies have examined OPN expression in salivary gland carcinomas with contradictory results. METHODS: One hundred and seventy-five patients with a primary salivary gland carcinoma diagnosed from January 1, 1990 to December 31, 2005 were identified in the local pathology register, Odense University Hospital. Criteria as documented by Allred et al. were used to assess OPN immunostaining that was performed on surgical specimens. RESULTS: Osteopontin was expressed in all salivary gland carcinomas. Adenoid cystic carcinomas had the highest mean sum score (7.3) and a significantly higher proportion of carcinomas with high OPN sum score than both mucoepidermoid carcinoma and acinic cell carcinoma. Correlation of OPN expression with known prognostic factors in salivary gland carcinomas was insignificant. CONCLUSIONS: Salivary gland carcinomas express OPN. The expression does not correlate with known prognostic factors. J Oral Pathol Med (2011) 40: 451-455
引用
收藏
页码:451 / 455
页数:5
相关论文
共 17 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]  
[Anonymous], 2005, TUMOURS SALIVARY GLA
[3]   EXPRESSION AND DISTRIBUTION OF OSTEOPONTIN IN HUMAN TISSUES - WIDESPREAD ASSOCIATION WITH LUMINAL EPITHELIAL SURFACES [J].
BROWN, LF ;
BERSE, B ;
VANDEWATER, L ;
PAPADOPOULOSSERGIOU, A ;
PERRUZZI, CA ;
MANSEAU, EJ ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (10) :1169-1180
[4]   Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies [J].
Coppola, D ;
Szabo, M ;
Boulware, D ;
Muraca, P ;
Alsarraj, M ;
Chambers, AF ;
Yeatman, TJ .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :184-190
[5]   Osteopontin expression in salivary gland tumours [J].
Darling, MR ;
Gauthier, M ;
Jackson-Boeters, L ;
Daley, TD ;
Chambers, AF ;
Tuck, AB .
ORAL ONCOLOGY, 2006, 42 (04) :363-369
[6]   Osteopontin expression and prognostic significance in non-small cell lung cancer [J].
Donati, V ;
Boldrini, L ;
Dell'Omodarme, M ;
Prati, MC ;
Faviana, P ;
Camacci, T ;
Lucchi, M ;
Mussi, A ;
Santoro, M ;
Basolo, F ;
Fontanini, G .
CLINICAL CANCER RESEARCH, 2005, 11 (18) :6459-6465
[7]   Prognostic significance of osteopontin expression in human prostate cancer [J].
Forootan, SS ;
Foster, CS ;
Aachi, VR ;
Adamson, J ;
Smith, PH ;
Lin, K ;
Ke, YQ .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (09) :2255-2261
[8]   Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer [J].
Hu, Z ;
Lin, DM ;
Yuan, JS ;
Xiao, T ;
Zhang, HS ;
Sun, WY ;
Han, NJ ;
Ma, Y ;
Di, XB ;
Gao, MX ;
Ma, JF ;
Zhang, JH ;
Cheng, SJ ;
Gao, YN .
CLINICAL CANCER RESEARCH, 2005, 11 (13) :4646-4652
[9]   Osteopontin as a potential diagnostic biomarker for ovarian cancer [J].
Kim, JH ;
Skates, SJ ;
Uede, T ;
Wong, KK ;
Schorge, JO ;
Feltmate, CM ;
Berkowitz, RS ;
Cramer, DW ;
Mok, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13) :1671-1679
[10]   Expression of bone matrix proteins, osteonectin and osteopontin, in salivary pleomorphic adenomas [J].
Kusafuka, K ;
Yamaguchi, A ;
Kayano, T ;
Takemura, T .
PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (11) :733-739